Merit Medical Systems Inc (MMSI)
97.60
-1.47
(-1.48%)
USD |
NASDAQ |
Nov 05, 11:17
Merit Medical Systems Enterprise Value: 6.001B for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 6.001B |
| November 01, 2024 | 5.985B |
| October 31, 2024 | 5.977B |
| October 30, 2024 | 5.758B |
| October 29, 2024 | 5.816B |
| October 28, 2024 | 5.782B |
| October 25, 2024 | 5.822B |
| October 24, 2024 | 5.814B |
| October 23, 2024 | 5.784B |
| October 22, 2024 | 5.798B |
| October 21, 2024 | 5.793B |
| October 18, 2024 | 5.850B |
| October 17, 2024 | 5.779B |
| October 16, 2024 | 5.778B |
| October 15, 2024 | 5.802B |
| October 14, 2024 | 5.794B |
| October 11, 2024 | 5.726B |
| October 10, 2024 | 5.691B |
| October 09, 2024 | 5.799B |
| October 08, 2024 | 5.803B |
| October 07, 2024 | 5.745B |
| October 04, 2024 | 5.800B |
| October 03, 2024 | 5.816B |
| October 02, 2024 | 5.858B |
| October 01, 2024 | 5.916B |
| Date | Value |
|---|---|
| September 30, 2024 | 5.987B |
| September 27, 2024 | 5.850B |
| September 26, 2024 | 5.843B |
| September 25, 2024 | 5.880B |
| September 24, 2024 | 5.962B |
| September 23, 2024 | 5.986B |
| September 20, 2024 | 5.960B |
| September 19, 2024 | 5.999B |
| September 18, 2024 | 5.910B |
| September 17, 2024 | 5.899B |
| September 16, 2024 | 5.965B |
| September 13, 2024 | 5.762B |
| September 12, 2024 | 5.752B |
| September 11, 2024 | 5.820B |
| September 10, 2024 | 5.797B |
| September 09, 2024 | 5.838B |
| September 06, 2024 | 5.786B |
| September 05, 2024 | 5.835B |
| September 04, 2024 | 5.768B |
| September 03, 2024 | 5.728B |
| August 30, 2024 | 5.792B |
| August 29, 2024 | 5.753B |
| August 28, 2024 | 5.742B |
| August 27, 2024 | 5.626B |
| August 26, 2024 | 5.582B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.819B
Minimum
Nov 11 2019
6.001B
Maximum
Nov 04 2024
3.855B
Average
3.858B
Median
Jun 30 2021
Enterprise Value Benchmarks
| Boston Scientific Corp | 133.49B |
| Abbott Laboratories | 211.48B |
| Baxter International Inc | 29.14B |
| Becton Dickinson & Co | 81.74B |
| Perspective Therapeutics Inc | 530.78M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 28.44M |
| Revenue (Quarterly) | 339.84M |
| Total Expenses (Quarterly) | 302.48M |
| EPS Diluted (Quarterly) | 0.48 |
| Gross Profit Margin (Quarterly) | 46.36% |
| Profit Margin (Quarterly) | 8.37% |
| Earnings Yield | 2.10% |
| Operating Earnings Yield | 2.66% |
| Normalized Earnings Yield | 2.097 |